Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Current Ratio | 2.87K | % | -31.6% |
Debt-to-equity | 91.4 | % | +87.8% |
Return On Equity | -94.3 | % | -107% |
Return On Assets | -49.3 | % | -61% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Entity Common Stock, Shares Outstanding | 172M | shares | +0.17% |
Common Stock, Shares, Outstanding | 172M | shares | +0.17% |
Entity Public Float | 6.6M | USD | +106% |
Common Stock, Value, Issued | 17.2K | USD | +0.17% |
Weighted Average Number of Shares Outstanding, Basic | 172M | shares | +0.18% |
Weighted Average Number of Shares Outstanding, Diluted | 172M | shares | +0.18% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Research and Development Expense | 1.68M | USD | +21.8% |
General and Administrative Expense | 1.97M | USD | -2.42% |
Operating Income (Loss) | -3.66M | USD | -7.41% |
Net Income (Loss) Attributable to Parent | -3.34M | USD | -10.3% |
Earnings Per Share, Basic | -0.02 | USD/shares | 0% |
Earnings Per Share, Diluted | -0.02 | USD/shares | 0% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Cash and Cash Equivalents, at Carrying Value | 5.61M | USD | -36.6% |
Assets, Current | 5.69M | USD | -36.4% |
Assets | 5.69M | USD | -36.4% |
Accounts Payable, Current | 15.9K | USD | -52.9% |
Accrued Liabilities, Current | 694K | USD | +9.87% |
Liabilities, Current | 710K | USD | +6.68% |
Liabilities | 3.71M | USD | +1.21% |
Retained Earnings (Accumulated Deficit) | -52.1M | USD | -6.85% |
Stockholders' Equity Attributable to Parent | 1.99M | USD | -62.4% |
Liabilities and Equity | 5.69M | USD | -36.4% |
Label | TTM Value / Value | Unit | Change % |
---|---|---|---|
Net Cash Provided by (Used in) Operating Activities | -1.16M | USD | -52.9% |
Net Cash Provided by (Used in) Financing Activities | -411K | USD | -922% |
Common Stock, Shares Authorized | 500M | shares | 0% |
Common Stock, Shares, Issued | 172M | shares | +0.17% |
Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.16M | USD | +0.87% |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 5.61M | USD | -36.6% |
Deferred Tax Assets, Valuation Allowance | 6.29M | USD | +15.4% |
Deferred Tax Assets, Gross | 6.29M | USD | +15.4% |
Deferred Tax Assets, Operating Loss Carryforwards | 4.04M | USD | +15% |
Additional Paid in Capital | 54.1M | USD | +0.07% |